Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Doi

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Journal of Cardiology Cases|January 13, 2021
Percutaneous transseptal transcatheter mitral valve-in-valve replacement for degenerated mitral bioprosthesis: The first experience in JapanHiroshi Ueno, Yuki Hida, Yohei Ueno, et al.
The Journal of Medical Investigation : JMI|October 5, 2018
Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic NephropathyHideharu Abe, Akiko Sakurai, Hiroyuki Ono, et al.
CEN Case Reports|December 22, 2023
Effects of switching from agalsidase-α to agalsidase-β on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case reportHisato Shima, Takahiro Tsukimura, Tomoko Shiga, et al.
Artificial Organs|May 6, 2015
Re-evaluation of Pre-pump Arterial Pressure to Avoid Inadequate Dialysis and Hemolysis: Importance of Prepump Arterial Pressure Monitoring in Hemodialysis PatientsEriko Shibata, Kojiro Nagai, Risa Takeuchi, et al.
The Journal of Medical Investigation : JMI|May 9, 2019
The utility and limitation of inferior vena cava diameter as a dry weight markerEriko Shibata, Kojiro Nagai, Sayo Ueda, et al.
Diabetes|August 29, 2006
RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparinKhin-Mar Myint, Yasuhiko Yamamoto, Toshio Doi, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Receptor for advanced glycation end products is a promising target of diabetic nephropathyYasuhiko Yamamoto, Toshio Doi, Ichiro Kato, et al.
The Journal of Biological Chemistry|July 29, 2011
SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathySeiji Kishi, Hideharu Abe, Haruhiko Akiyama, et al.
The Journal of Medical Investigation : JMI|November 5, 2020
Clinical characteristics associated with 1-year tolvaptan efficacy in autosomal dominant polycystic kidney disease with a wide range of kidney functionsTaichi Murakami, Kenji Nishimura, Hiroyuki Ono, et al.
Nihon Jinzo Gakkai Shi|March 5, 2011
[Case of renal artery stenosis in an elderly patient after nephrectomy diagnosed by ultrasound sonography, showing improvement of blood pressure and renal dysfunction after renal artery stenting]Kojiro Nagai, Kenya Kusunose, Susumu Nishio, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Journal of Cardiology Cases|January 13, 2021
Percutaneous transseptal transcatheter mitral valve-in-valve replacement for degenerated mitral bioprosthesis: The first experience in JapanHiroshi Ueno, Yuki Hida, Yohei Ueno, et al.
The Journal of Medical Investigation : JMI|October 5, 2018
Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic NephropathyHideharu Abe, Akiko Sakurai, Hiroyuki Ono, et al.
CEN Case Reports|December 22, 2023
Effects of switching from agalsidase-α to agalsidase-β on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case reportHisato Shima, Takahiro Tsukimura, Tomoko Shiga, et al.
Artificial Organs|May 6, 2015
Re-evaluation of Pre-pump Arterial Pressure to Avoid Inadequate Dialysis and Hemolysis: Importance of Prepump Arterial Pressure Monitoring in Hemodialysis PatientsEriko Shibata, Kojiro Nagai, Risa Takeuchi, et al.
The Journal of Medical Investigation : JMI|May 9, 2019
The utility and limitation of inferior vena cava diameter as a dry weight markerEriko Shibata, Kojiro Nagai, Sayo Ueda, et al.
Diabetes|August 29, 2006
RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparinKhin-Mar Myint, Yasuhiko Yamamoto, Toshio Doi, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Receptor for advanced glycation end products is a promising target of diabetic nephropathyYasuhiko Yamamoto, Toshio Doi, Ichiro Kato, et al.
The Journal of Biological Chemistry|July 29, 2011
SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathySeiji Kishi, Hideharu Abe, Haruhiko Akiyama, et al.
The Journal of Medical Investigation : JMI|November 5, 2020
Clinical characteristics associated with 1-year tolvaptan efficacy in autosomal dominant polycystic kidney disease with a wide range of kidney functionsTaichi Murakami, Kenji Nishimura, Hiroyuki Ono, et al.
Nihon Jinzo Gakkai Shi|March 5, 2011
[Case of renal artery stenosis in an elderly patient after nephrectomy diagnosed by ultrasound sonography, showing improvement of blood pressure and renal dysfunction after renal artery stenting]Kojiro Nagai, Kenya Kusunose, Susumu Nishio, et al.
Pageof 21